Searched for
GEMCITABINE
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Dr Reddy's Laboratories shares rise 2% after launching drug to treat nasopharyngeal cancerDr Reddy's Laboratories has launched toripalimab, an immune oncology drug for adults with recurrent or metastatic nasopharyngeal carcinoma ...
- Dr Reddy's launches drug for neck, head cancerDr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This d...
- Dr Reddy's launches novel cancer therapy Toripalimab in IndiaDr. Reddy’s has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma ...
- Alembic Pharma gets USFDA nod for cancer treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) fo...
- Sun Pharma gets USFDA nod for cancer treatment injectionThe approval from the USFDA is for INFUGEM injection (gemcitabine in 0.9 per cent sodium chloride injection) 10 mg/mL, for intravenous use ...
- NPPA fixes retail price of 30 drug formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...
- PMBJPs selling drugs up to 96% cheaper than branded equivalentsMandaviya, in a written reply in the Lok Sabha , said that the branded generic medicines are generally sold at higher prices in comparison ...
- Sun launches ready-to-administer chemotherapy drugSun Pharma said Gemcitabine InfuSMART is the world’s first licensed RTA product, which was developed by its R&D team in India.
- Sun Pharma starts rollout of Gemcitabine InfuSMART in six European nationsGemcitabine is indicated in the treatment of ovarian, lung, breast and pancreatic cancer. Sun Pharma hinted at more oncology products being...
- Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US salesThe facility is important for the company as its contributes to around 40 per cent of US sales and around 25 per cent of consolidated profi...
- Venus Remedies rallies on getting marketing approval in SwitzerlandThe marketing approval for Gemcitabine will help the company further strengthen its oncology portfolio and improve its presence in this spa...
- India based Venus Remedies gets market authorisation for oncology drugs from Swiss authorityChandigarh based pharma company Venus Remedies gets green signal for maket authorisation of oncology drugs from Swiss drug authority
- Sun Pharmaceutical Industries recalls 200 vials of cancer drug, Gemcitabine from US marketSun Pharmaceutical has recalled 200 vials of cancer drug Gemcitabine for injection from the US market for lack of assurance of sterility.
- Two-drug combo pill to treat HIVScientists have developed a new delivery system for a combination of two HIV drugs that may serve as an effective treatment for the deadly ...
- Venus receives nod for four plants from Australian authorityVenus Remedies has received approval from Australian authorities for 4 of its facilities, thus enabling the company to export products from...
- Strides Arcolab gets USFDA nod for cancer injectionDrug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...
- Venus Remedies get UK approval for cancer drug; stock upVenus Remedies has received UK MHRA approval for drug Gemcitabine, one of the key products for treatment of cancer.
- Shilpa Medicare gets suitability certificate for Oxaliplatin EPShilpa Medicare has received the certificate of suitability of Monographs from European Directorate for the Quality of Medicines for the ac...
- Sun Pharma gets approval for Gemzar injectionSun Pharmaceutical Industries has received approval from USFDA for the abbreviated new drug application for its generic version of Eli Lill...
Load More
